Loading…
Bioverse, Inc. is a company that was selling drugs to U.S. consumers via the internet without FDA approval and in violation of labeling requirements. The FDA's Center for Drug Evaluation and Research (CDER) issued a warning letter on September 9, 2025, citing the unlawful distribution of unapproved and misbranded drug products. Based on the available metadata alone, the specific drug products and detailed violations cannot be determined without review of the complete warning letter.